Supplement of Bifico Capsule Alternates Gut Microbiota in Colorectal Cancer Patients Receiving Chemotherapy

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800018191

Enrollment

Unknown

Registered

2018-09-04

Start date

2018-10-01

Completion date

Unknown

Last updated

2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Case series:Bifico

Eligibility

Sex/Gender

All

Age

40 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. diagnosis of colorectal cancer through pathology; 2. receiving curative surgery and subsequent chemotherapy; 3. KPS scores over 60 and age between 20-70; 4. non-pregnant nor lactating with expected survival time over 6 months; 5. without severe infection and other medical situation that impetes the experiment; 6. Informed consented and be able to complete following up.

Exclusion criteria

Exclusion criteria: 1. severe uncontrolled infection; 2. other severe illness or metal disturbance; 3. unwilling to take drug or unable to evaluate results.

Design outcomes

Primary

Measure	Time frame
Abundance of Clostridium Symbiosum;Abundance of Fusobacterium Nucleatum;survival time;	—

Secondary

Measure	Time frame
Kamofsky scores;QOL scores;tumor markers;	—

Countries

China

Contacts

Public ContactXie Yuanhong

Shanghai Jiaotong University School of Medicine Affiliated Renji Hospital

phoenix_xyh123@163.com+86 21 53882332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026